Two common antibiotics used for serious skin infections—clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) —both had about an 80% success rate in curing uncomplicated methicillin-resistant Staphylococcus aureus (MRSA) skin infections, according to a study today in the New England Journal of Medicine (NEJM).
A 72-year-old Saudi woman has died of MERS-CoV in Buraydah, and a previously reported MERS patient has also died, the country's Ministry of Health (MOH) said today as a top official noted more international help with the outbreak.
The median duration of colonization with community-based methicillin-resistant Staphylococcus aureus (MRSA) in ambulatory patients is 21 days, shorter than the previously thought duration of 6 to 9 months, and treatment with clindamycin is associated with more rapid clearance of the infection, say findings of a study published yesterday in Clinical Infectious Diseases.
Findings presented at a major infectious disease conference in Philadelphia today suggest that hospital antibiotic stewardship programs can pay unexpected benefits in children.
A federal vaccine advisory group yesterday recommended that adults age 65 and older receive the Prevnar 13 pneumococcal conjugate vaccine, according to a press release from Pfizer Inc., the vaccine's maker. Using the vaccine alongside the current 23-valent pneumococcal vaccine is thought to provide broader protection.
The US Food and Drug Administration (FDA) has approved tedizolid phosphate (Sivextro), a new antibacterial drug to treat adults with acute bacterial skin and skin structure infections (ABSSSI), the agency announced on Jun 20.
The IDSA stressed that many infections heal on their own or don't need antibiotics.
The evidence-based guidance is part of a series on preventing hospital infections.
The US Centers for Disease Control and Prevention (CDC) today warned health providers that the number of imported chikungunya cases is likely to increase, given ongoing outbreaks in Caribbean countries and territories and some parts of South America, according an update in Morbidity and Mortality Weekly Report (MMWR).
A 4-year survey of methicillin-resistant Staphylococcus aureus (MRSA) at five medical centers across the United States found that the incidence of community-onset (CO) MRSA cases varied considerably, with trends in New York City and Los Angeles going in opposite directions, according to a report in Clinical Infectious Diseases.
